Flowsense Surges Most in 3 Months on U.S. Distribution Deal

Flowsense Medical Ltd. (FLSN) surged the most in almost three months after the maker of an automated urine monitor system signed a memorandum of understanding with a U.S. distributor for the marketing of its URINFO 2000 system.

The shares (FLSN) surged 9.1 percent, the biggest jump since Oct. 5, to 0.084 shekel at the 4:30 p.m. close in Tel Aviv.

Flowsense said it signed the agreement with Doctors Oxygen Services Inc., a distributor of equipment to hospitals in the U.S., to market its URINFO 2000 system in some parts of the country, according to a filing with the Tel Aviv Stock Exchange today. Flowsense said the parties are working toward the completion of a detailed distribution agreement by Jan. 31.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.